http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 17 Jun 2026 16:50:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CONMED+Corp+++++++++++++++For%3A+Jun+17/26660702.html si-local-file:///var/storage/secattach/20260617/26660702.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CONMED+Corp+++++++++++++++For%3A+Jun+17/26660702.html Wed, 17 Jun 2026 16:50:00 -0400 CNMD O.00046757 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CONMED+Corp+++++++++++++++For%3A+Jun+17/26660702.html si-local-file:///var/storage/secattach/20260617/26660702.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CONMED+Corp+++++++++++++++For%3A+Jun+17/26660702.html Wed, 17 Jun 2026 16:50:00 -0400 CNMD O.00046757 http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html <p>CONMED Corporation (NYSE: CNMD) has appointed John E. Gallagher as Chief Financial Officer, effective July 15, 2026, according to a press release from the medical technology company.</p> <p>Gallagher succeeds Todd Garner, who will remain with the company in an advisory capacity through November 2, 2026.</p> <p>Gallagher brings nearly three decades of financial experience, most recently serving as CFO of Certara, Inc., a publicly traded pharmaceutical technology and services company, beginning in 2023. Prior to that, he served as CFO of Cue Health Inc. from 2021 to 2023.</p> <p>He previously spent nine years at Becton, Dickinson & Co., where he held several roles including http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html Wed, 17 Jun 2026 16:35:11 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html <p>CONMED Corporation (NYSE: CNMD) has appointed John E. Gallagher as Chief Financial Officer, effective July 15, 2026, according to a press release from the medical technology company.</p> <p>Gallagher succeeds Todd Garner, who will remain with the company in an advisory capacity through November 2, 2026.</p> <p>Gallagher brings nearly three decades of financial experience, most recently serving as CFO of Certara, Inc., a publicly traded pharmaceutical technology and services company, beginning in 2023. Prior to that, he served as CFO of Cue Health Inc. from 2021 to 2023.</p> <p>He previously spent nine years at Becton, Dickinson & Co., where he held several roles including http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html Wed, 17 Jun 2026 16:35:11 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html <p>CONMED Corporation (NYSE: CNMD) has appointed John E. Gallagher as Chief Financial Officer, effective July 15, 2026, according to a press release from the medical technology company.</p> <p>Gallagher succeeds Todd Garner, who will remain with the company in an advisory capacity through November 2, 2026.</p> <p>Gallagher brings nearly three decades of financial experience, most recently serving as CFO of Certara, Inc., a publicly traded pharmaceutical technology and services company, beginning in 2023. Prior to that, he served as CFO of Cue Health Inc. from 2021 to 2023.</p> <p>He previously spent nine years at Becton, Dickinson & Co., where he held several roles including http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html Wed, 17 Jun 2026 16:35:11 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html <p>CONMED Corporation (NYSE: CNMD) has appointed John E. Gallagher as Chief Financial Officer, effective July 15, 2026, according to a press release from the medical technology company.</p> <p>Gallagher succeeds Todd Garner, who will remain with the company in an advisory capacity through November 2, 2026.</p> <p>Gallagher brings nearly three decades of financial experience, most recently serving as CFO of Certara, Inc., a publicly traded pharmaceutical technology and services company, beginning in 2023. Prior to that, he served as CFO of Cue Health Inc. from 2021 to 2023.</p> <p>He previously spent nine years at Becton, Dickinson & Co., where he held several roles including http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html Wed, 17 Jun 2026 16:35:11 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html <p>CONMED Corporation (NYSE: CNMD) has appointed John E. Gallagher as Chief Financial Officer, effective July 15, 2026, according to a press release from the medical technology company.</p> <p>Gallagher succeeds Todd Garner, who will remain with the company in an advisory capacity through November 2, 2026.</p> <p>Gallagher brings nearly three decades of financial experience, most recently serving as CFO of Certara, Inc., a publicly traded pharmaceutical technology and services company, beginning in 2023. Prior to that, he served as CFO of Cue Health Inc. from 2021 to 2023.</p> <p>He previously spent nine years at Becton, Dickinson & Co., where he held several roles including http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html Wed, 17 Jun 2026 16:35:11 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html <p>CONMED Corporation (NYSE: CNMD) has appointed John E. Gallagher as Chief Financial Officer, effective July 15, 2026, according to a press release from the medical technology company.</p> <p>Gallagher succeeds Todd Garner, who will remain with the company in an advisory capacity through November 2, 2026.</p> <p>Gallagher brings nearly three decades of financial experience, most recently serving as CFO of Certara, Inc., a publicly traded pharmaceutical technology and services company, beginning in 2023. Prior to that, he served as CFO of Cue Health Inc. from 2021 to 2023.</p> <p>He previously spent nine years at Becton, Dickinson & Co., where he held several roles including http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html Wed, 17 Jun 2026 16:35:11 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html <p>CONMED Corporation (NYSE: CNMD) has appointed John E. Gallagher as Chief Financial Officer, effective July 15, 2026, according to a press release from the medical technology company.</p> <p>Gallagher succeeds Todd Garner, who will remain with the company in an advisory capacity through November 2, 2026.</p> <p>Gallagher brings nearly three decades of financial experience, most recently serving as CFO of Certara, Inc., a publicly traded pharmaceutical technology and services company, beginning in 2023. Prior to that, he served as CFO of Cue Health Inc. from 2021 to 2023.</p> <p>He previously spent nine years at Becton, Dickinson & Co., where he held several roles including http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html Wed, 17 Jun 2026 16:35:11 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html <p>CONMED Corporation (NYSE: CNMD) has appointed John E. Gallagher as Chief Financial Officer, effective July 15, 2026, according to a press release from the medical technology company.</p> <p>Gallagher succeeds Todd Garner, who will remain with the company in an advisory capacity through November 2, 2026.</p> <p>Gallagher brings nearly three decades of financial experience, most recently serving as CFO of Certara, Inc., a publicly traded pharmaceutical technology and services company, beginning in 2023. Prior to that, he served as CFO of Cue Health Inc. from 2021 to 2023.</p> <p>He previously spent nine years at Becton, Dickinson & Co., where he held several roles including http://www.streetinsider.com/Management+Changes/CONMED+names+John+Gallagher+as+CFO%2C+effective+July+2026/26660482.html Wed, 17 Jun 2026 16:35:11 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Press+Releases/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266 http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html <p> LARGO, Fla.--(BUSINESS WIRE)-- <b>CONMED Corporation (NYSE: CNMD) </b>today announced the appointment of John E. Gallagher as Chief Financial Officer (“CFO”), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with the Company in an advisory capacity through November 2, 2026. </p><p> “We are pleased to welcome a talented and experienced financial executive of John’s caliber to CONMED,” said Patrick J. Beyer, CONMED’s President and Chief Executive Officer. “John brings deep healthcare and medical technology experience, an extensive history of public company leadership, and a proven track record of leading global finance organizations and supporting complex strategic initiatives. http://www.streetinsider.com/Business+Wire/CONMED+Corporation+Appoints+John+E.+Gallagher+as+Chief+Financial+Officer/26660481.html Wed, 17 Jun 2026 16:35:00 -0400 A.01615153 A.17875977 A.40824999 CNMD O.00046757 O.01214331 O.01402212 O.01897266